This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jubilant Episcribe LLC. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations of Manish Kumar Thakur
Introduction
Manish Kumar Thakur is an accomplished inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
One of his notable patents is titled "Heterocyclic compounds as PRMT5 inhibitors." This patent describes compounds of Formula I, Formula Ia, and Formula Ib, along with their analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites, and prodrugs. These compounds are designed to inhibit PRMT5 and are useful as therapeutic agents for diseases related to cellular growth, including malignant tumors, schizophrenia, Alzheimer's disease, and Parkinson's disease. Manish holds 1 patent in this area.
Career Highlights
Manish Kumar Thakur is currently employed at Jubilant Episcribe LLC, where he continues to innovate and develop new therapeutic compounds. His work is pivotal in advancing treatments for various serious health conditions.
Collaborations
He collaborates with talented coworkers such as Dhanalakshmi Sivanandhan and Tamizharasan Natarajan, contributing to a dynamic research environment.
Conclusion
Manish Kumar Thakur's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions are paving the way for new therapeutic options for challenging diseases.